Market Place
Sourcing Support
Quoin Pharma Updates FDA On QRX003 For Netherton Syndrome
25 Mar 2026 //
GLOBENEWSWIRE
Quoin Pharma Gets FDA Fast Track For QRX003 In Netherton Syndrome
12 Mar 2026 //
GLOBENEWSWIRE
Netherton Now Spotlights Netherton Syndrome on Rare Disease Day
26 Feb 2026 //
GLOBENEWSWIRE
Quoin Submits QRX003 For Orphan Designation In Netherton Syndrome
27 Jan 2026 //
GLOBENEWSWIRE
Quoin Pharma Seeks Breakthrough Designation For QRX003
20 Jan 2026 //
GLOBENEWSWIRE
Quoin Hits Target Loadings For Two Topical Rapamycin Platforms
11 Nov 2025 //
GLOBENEWSWIRE
Quoin Adds 3 Patients, Shares Positive 9-Month Data in Netherton
28 Oct 2025 //
GLOBENEWSWIRE
Quoin Get FDA Orphan Drug Status For QRX003 In Netherton Syndrome
21 Oct 2025 //
GLOBENEWSWIRE
Quoin Pharma Secures $104.5M Financing In Private Placement
10 Oct 2025 //
GLOBENEWSWIRE
Quoin`s NETHERTON NOW Campaign For Netherton Syndrome Awareness
21 Aug 2025 //
GLOBENEWSWIRE
FDA Grants RPD Tag to QRX003 for Netherton Syndrome
24 Jun 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals gets FDA clearance for QRX003 study
22 May 2025 //
GLOBENEWSWIRE
Quoin Pharma EMA Grants Orphan Drug Designation for QRX003
20 May 2025 //
GLOBENEWSWIRE
Quoin Reports Positive QRX003 Data in Pediatric Skin Study
14 May 2025 //
GLOBENEWSWIRE
Quoin Report Pediatric Netherton Data, Approval for Patient Testing
02 Apr 2025 //
GLOBENEWSWIRE
Quoin Files Patents For Novel Topical Rapamycin In Rare Diseases
04 Mar 2025 //
GLOBENEWSWIRE
Quoin Pharma Launches Campaign for Netherton Syndrome Awareness
04 Feb 2025 //
GLOBENEWSWIRE
Quoin Shows QRX003 Effectiveness In Treating Netherton Syndrome
23 Jan 2025 //
GLOBENEWSWIRE
Quoin Pharma Reports Data From Pediatric Netherton Syndrome Study
14 Jan 2025 //
GLOBENEWSWIRE
Quoin Reports Positive Data On Netherton Syndrome Clinical Study
06 Jan 2025 //
GLOBENEWSWIRE
Quoin Announces FDA Clearance for QRX003 Netherton Syndrome Study
19 Dec 2024 //
GLOBENEWSWIRE
Quoin Pharma Initiates Pediatric Testing for Netherton Syndrome
05 Nov 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals to Report Q3 2024 Results on Nov 7
31 Oct 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Expands International Trials For Netherton
22 Oct 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Insider Share Purchases
09 Sep 2024 //
GLOBENEWSWIRE
Quoin Announces Clearance to Recruit Subjects into Netherton Syndrome Studies
04 Mar 2024 //
GLOBENEWSWIRE
Quoin Files Patent Applications for Novel Netherton Syndrome Product
08 Feb 2024 //
GLOBENEWSWIRE
Quoin Announces Additional Positive Data in Netherton Syndrome
24 Oct 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Data from Open-Label in Netherton Syndrome
24 Oct 2023 //
GLOBENEWSWIRE
Quoin Pharma Announces 50% Enrollment in Open Label Netherton Syndrome Trial
24 May 2023 //
GLOBENEWSWIRE
Quoin Doses First Patient in Open Label Netherton Syndrome Clinical Trial
21 Mar 2023 //
GLOBENEWSWIRE
